Keywords: FDA, Pfizer, Prevnar 13, Pneumococcal vaccine

US FDA advisory panel backs Pfizer’s Prevnar 13

Article | 20 November 2009

Print This

The US Food and Drug Administration’s Vaccines and Related Biological Products advisory committee voted in favor (10 to one) of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in